Actively Recruiting
YAG Laser Vitreolysis for Vitreous Floaters
Led by VMR Consulting, Inc. · Updated on 2026-02-27
50
Participants Needed
1
Research Sites
132 weeks
Total Duration
On this page
Sponsors
V
VMR Consulting, Inc.
Lead Sponsor
T
The Retina Clinic - London Ophthalmic Institute
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to measure how the quality of life, the structure of eye, and vision change after treatment for the opacities in the gel (vitreous) that fills the center of eye which cause vision disturbances commonly called "floaters". In this study the vitreous floaters are treated using a Neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser. The FDA has approved the use of this laser to treat membranes in the eye.
CONDITIONS
Official Title
YAG Laser Vitreolysis for Vitreous Floaters
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Only one eye per patient will be included in this study
- Able and willing to give informed consent
- Age 18 years or older
- Suffering from symptomatic vitreous floaters
- Floaters caused by myopic vitreopathy or posterior vitreous detachment
- Floaters present for at least 3 months
- One or more dense and well-defined vitreous opacities
- Floaters include a Weiss Ring or opacities within the safety zone at least 3mm from the retina and 6mm from the lens
- Floaters visible on contact lens biomicroscopy
You will not qualify if you...
- Vitreous opacities outside the safety area (less than 3mm from the retina or less than 6mm from the lens)
- Clinically significant cataract affecting vision more than vitreous opacities or expected cataract surgery during the study
- Untreated retinal tears or holes requiring treatment
- High risk of peripheral lesions requiring treatment
- Synchysis scintillans (vitreous opacities from old blood)
- Asteroid hyalosis (vitreous opacities from cholesterol)
- Vitreous hemorrhage (fresh blood in the eye center)
- Active photopsia (flashing lights)
- History of previous YAG laser vitreolysis or vitrectomy for any condition
- Posterior vitreous detachment within the past 3 months
- Unable to attend study appointments
- Any other significant ocular or non-ocular condition that risks safety or affects study results
- Intraocular surgery within 6 months before study entry
- Retinal laser treatment within 2 months before study entry
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
VMR Institute for Vitreous Macula Retina
Huntington Beach, California, United States, 92647
Actively Recruiting
Research Team
D
Dr Jerry Sebag, MD, FACS, FRCOphth, FARVO
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here